Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good morning,
Let's face it, this is good news just on the surface of getting a product into retail circulation. Ceo states that this product is a 125m$ market value and that bodes well for a penny company. So, we get .005 of this 125m$ piece of the pie at sales of 650K$. This isn't bad and from what I gather the endorsement from this celeb. is on itself a huge get.
Bring on the next contract.
Have a good day
varok
I certainly can understand taking profits off the table. This is one issue that you had to make such a move. However, what is being caught up in this profit taking is the expansion into anxiety and emotion, which is now in the area of being stupid and panic selling. This churning was an absolute must, but for it to go down to this level is beyond belief. but certainly, a good area to average down and grab some more shares and for you folks sitting on the fence, is now a buying opportunity.
This company has legs.
Have a good day
varok
Good morning,
The churning is a welcomed event and much needed for us to establish support. This issue for all the right reasons went ballistic and is just plain awesome.
The capital infusion is absolutely a phenonium on many levels and will change the dynamics from the EV battery to this abundance supply of fuel in the coming years. The industry needed to find an alternative to the very expensive battery and the finite supply of the rare elements that go into just one battery.
Welcome to hydrogen next generation fuel at a very inexpensive rate.
This is an absolute buy under .02. I see $1.00 without much effort for 2024, but .50 will work for the interim.
Have a good day
varok
Just ignore this guy's post!
Total BS. Anybody that goes back 4-5 on a penny stock is a fool.
For you folks that are fence sitters today is your day to acquire some nice shares at a low price.
Have a good day
varok
On the wall with CSTI.
Mr. koolmac mentioned something was up and this I believe is his (CSTI) problem.
CSTI bit off a little too much yesterday and grabbed up the sellers and basically sat on it and incidentally is a no-no. I'm not sure what he was thinking, but now either he takes it lower to get out of the 23m, or he will sit here and hope he can break even, but either way, he needs to get out. See, MM cannot hold inventory and he is stuck, so for you folks that want in, let him sweat a little and when he takes it lower, grab them.
See ya
varok
Good morning,
Congrats to all that bought into the low of yesterday at .0017. Believe me, this issue is the one of the few in the penny arcade that is going to be the ultimate and one of the biggest gains for 2024 and the 1st quarter of 2025.
This is a rare gem in the works.
See you all after Labor Day for the fun ride into fall.
Have a good day.
varok
Well, I'm taking on more at this level. I believe the company does have viable contracts in the works and when it comes to their business model. I think thus far it is the best in the cannabis space.
I really believe the rev can absorb the additional shares and we are only looking at 368m more, really not a big deal. However, this can't go on forever and a PR is and should be the order of the day on this matter.
Yes, the current climate is ugly, but the volume is still very low, and the rebound will be awesome. Let me first to say that the fair value is really at this level, and we are now in oversold territory and the rebound will likely happen shortly.
Explaining fair value. The company stated in the recent PR that net income was 3.8m$ and was based on the buyback as a major benefactor. So, currently we are actually oversold, but at fair value. Share price X MC = Fair Value. So with this example and let's say 1B O/S giving us almost 3m$ MC. This is in line with financial and any announcement on new contracts will give us the bounce back to .004-.005.
Remember in the penny arcade sophisticated accounting methods is not a viable indicator. Only 2 things matter in the pinks, it is share price and current O/S = MC. No P/E or the other terms are relevant. It is straight up accounting.
Have a good day
varok
Good morning,
Well, that is certainly a rude awakening on the Conv D. So here is what we can expect. Since the last annual financial conv D had 6,200m A/S and 3,864M O/S. So, what the company is saying that they are Coverting a number of O/S. So here is what the conversion rate stands. For every 1 share of convert D is 100 shares into common. This means we are converting into common 386M. Ok that outs us just under 1B O/S when and if the total is converted.
If it means anything, I have not after this that changes my assessment going into the next year mid 2025 target. Even a O/S of 1B is still within reason, but as I have mentioned, we must keep an eye on the share structure, but I'm close to the figure that will be the eventual outcome.
Let's hope that rev will compensate the difference. I'm still very bullish.
Have a good day
varok
This may be of interest to you all. I wrote this back in 2019 on how 2 Market makers play in this venue. Now they are #1and 2 on the ask. Notice Nite well below on the ask and the top on the bid, the 2 primary players are CDEL and CSTI on the ask.
MARKET MAKER - CDEL
I wrote this about CDEL 2019
Things have drastically changed with respect to CDEL over the last 3-5 years.
I know CDEL and what they consist within the pennyarcade and the overall trading sessions.
CDEL is a very large institution that comprises of many facets. First and foremost, they have the largest electronic trading platforms that is larger than Nasdaq.
They control over 35% of the volume that is traded through their systems and why you see them always ping ponging along with NITE.
Their only competition in handle large volume trades is NITE. When some of you came back and mentioned they are retail and doesn't do dilution or convertible/toxic debt financing is not accurate. They are one of the largest purveyors of shorting, conversion on convertible notes and yes Toxic Debt instruments. Not to mention that options trading is their bread and butter, and they are the largest in the world in this venue.
Second, CDEL runs one of the most successful global hedge funds and is very large in institutional buying and selling that far exceeds general retail outside of their electronic volume handling.
Someone mentioned about the 5th decimal yesterday, that there were some trades going through on the 5th decimal. That folk is institutional buying, not retail!! And it was CDEL that handled that part. Of course, it may also be trading among themselves to handle so called mask trades, which we see a lot of. This is simply a share amount like CDEL does a lot and notes only a 5,000-share count but seems never to leave.
CDEL was in front of all the trades. CDEL and most of their business is institutional. When some of you see CDEL who executed, is only because their Electronic Trading platform got routed, but their retail is for mostly their clients, but dwarfs compared to institutional.
This MM CSTI, is the problem with this shorting.
Also, let me mention that CSTI who is the second player along with NITE and is a European MM out of the UK and is allowed to short pennystocks. In the states where shorting pennystocks isn't allowed is where this MM (CSTI)is running interference for NITE.
However, CSTI isn't really playing in this sandbox, but that will change once we get that catalyst
Most of the popular penny stock MM route through NITE because they are quick to execute most orders, but CDEL is very much in this venue and competes with NITE
Each market maker has its own complex algorithm that tries to make trades and CDEL is considered to be the world's finest.
Many times, they do this by shorting the ask and then covering on the bid. It is here with respect to CDEL, CSTI and NITE bounce back and forth and what we have been witnessing in the last many sessions.
Sometimes when a stock is running and you place an order on the ask and you don’t get filled, it is actually the market maker taking shares on the ask.
Then they move up the bid and again is where CDEL shows up and NITE trails. Then on the ask and tries to bait traders into hitting the ask again to sell the shares that they just bought. This happened a lot and resulted in a deep slide and took out the emotional holders of which, I believe were not the Level II traders, but saw the quote and WOW!! panicked.
You will also see MM’s shorting a stock as it runs up because they know that it will eventually come down. Think of it this way. If they are able to short a stock at .17 and it runs to .19, you will hear people on the forums, or a market maker is short.
In reality, it really won’t matter because naked or shorting really isn’t enforced in Europe and Canada where it is legal and any short will eventually be able to cover, if then they just keeping shorting more. Here is where I believe CDEL played and accommodated emotional traders into selling.
So far, every indication that the share structure hasn't changed, and the O/S shares the float is in strong hands appears CDEL is a major buyer at this time.
The problem we have here is CDEL is playing counterweight.
Have a good day
varok
TD Ameritrade is now schwab
The Sunday Newsletter - BLEG
Let's recap last week's trading session.
There were much frustrated feelings in the past week, and most was based on the anticipated inspection on the manufacturing facility and as usual, some took it has a negative and prematurely exited out. Folks, nothing has changed with BLEG and I myself stand on the strengths of the company and not on daily unfortunate business cycles that is part of the ongoing operation. Snags happen in business, and this was nothing more than a hiccup and can easily be corrected. The usual remedy that always placates business cycles is to find a solution and correct the issue. This is being done as we speak. For people to sell on such a small deviate is really taking trading on emotion to a level that only frustrates one's own mind. Also, the daily trading volume is very low on this issue, and it only takes 10 -15% of the volume to take it down beyond reasonable levels before it gets correct and further fuels the downdraft that it takes other inexperienced traders with them and this is exactly what happened, it was all on anxiety, emotion and just plain nervousness that propelled one to sell. The company wasn't at fault as they explained quickly the issue of what happened and is working to correct it.
Let me say something about the manufacturing end of the company and what they are going through. The last 2 on Fridays tweet is the most difficult and is generally the last in line for acceptance for client approval and a contract signature. My family business is in manufacturing with the same hurdles as BLEG. We manufactured specialty ceramics that was based on the client's specifications. One of our clients is the automotive industry that required a 1"x1" ceramic chip that would go into a sheen diagnostic machine. This ceramic chip was opaque, and the constancy had to be so accurate that even a .00001% deviation from their specs. was inadequate and brought us back to the drawing board and our labs were so intensely frustrated that it took months to finally come to a successful conclusion that was accepted and finally the contract. The manufacturing end took enough time for quality and consistency and can we produce the 1/4 of a million with the same outcome as the original sample provided by the industry. Man, that was a real task to say the least. Many sleepless nights. Same went for reproductions in the antiquities from museums. This was our specialty, but just to mention what the company like BLEG has to go through to get the contract. The clients under these negotiations have the last say and the company if given the contract will be well deserved.
There are 3 important factors that you must understand when you take a position in a penny stock. The first is the share structure. What kills every penny company is the dilution of the share structure and it is indisputable to argue the fact that this one issue isn't the greatest negative to your ROI. The second is the business model. Does it have standing, and can it uphold the dominate interest with respect to rev and in a growth progression that is needed to continue through the business cycle for expansion and financing without the dilutive factor. The third is the management team. Does the company have the expertise in it respective field and does, this is important have the interest of shareholders concerns and updating said shareholders on every turn on the progression and missteps.
Al 3 of these attributes are in the company's favor. The company reduced the O/S shares by 2b and that is a big deal and shows that the company has the intent to build the business model from within and not on the backs of shareholders through dilutive nature. The business model is a concept that is revolutionary with respect to cannabis, which is and will gain much more popularity as more and more states recognize the viability for taxing and other reasons, but more importantly, the company is venturing in byproduct items that have appeal in broad sectors and with approval after clinical trials can only benefit the company as a whole with the utmost legitimacy. of FDA and other interested parties. Also, and this is important, the Vertical Integrated Structure. The company has in place every facet of the sequenced of the business model from the raw material through the manufacturing process onto the sales end into the public domain. This part allows the company absolute control from beginning to end without outsourcing that otherwise would create unnecessary bottlenecks and production delays. The last but not the least is the management team. So far, the company has shown transparency and the desire to keep shareholders in the loop. Also, the team has and is the original team before the company acquired their respective industries and this is very huge endeavor that allows the team a coordination that otherwise would be a stage of Imbo due to a training period that now doesn't exist, and you have harmony over the whole process.
Now we move forward into a growth period with an exciting company and a business model that is fairly new with respect to a business venture that is on the ground floor and the only way is up. I stand by my target of .01-.05 through mid-way 2025. The opportunities here is so great that after last week's downdraft, this issue is an absolute buying opportunity and feel you should take advantage and hold long. The next assessment will be June 2025. To give the company 1 year is certainly a reasonable objective for it to take their plan to the next level and that is a Nasdaq elevation, but that is down the road. Now it is in your court to fully embrace what a growth company feels like, and it is a buy and hold.
Remember, we have the May 15th quarter this week.
See you all on the trading floor tomorrow and Happy Mother's Day.
Have a good day
varok
The Sunday Newsletter - BLEG
Let's recap last week's trading session.
There were much frustrated feelings in the past week, and most was based on the anticipated inspection on the manufacturing facility and as usual, some took it has a negative and prematurely exited out. Folks, nothing has changed with BLEG and I myself stand on the strengths of the company and not on daily unfortunate business cycles that is part of the ongoing operation. Snags happen in business, and this was nothing more than a hiccup and can easily be corrected. The usual remedy that always placates business cycles is to find a solution and correct the issue. This is being done as we speak. For people to sell on such a small deviate is really taking trading on emotion to a level that only frustrates one's own mind. Also, the daily trading volume is very low on this issue, and it only takes 10 -15% of the volume to take it down beyond reasonable levels before it gets correct and further fuels the downdraft that it takes other inexperienced traders with them and this is exactly what happened, it was all on anxiety, emotion and just plain nervousness that propelled one to sell. The company wasn't at fault as they explained quickly the issue of what happened and is working to correct it.
Let me say something about the manufacturing end of the company and what they are going through. The last 2 on Fridays tweet is the most difficult and is generally the last in line for acceptance for client approval and a contract signature. My family business is in manufacturing with the same hurdles as BLEG. We manufactured specialty ceramics that was based on the client's specifications. One of our clients is the automotive industry that required a 1"x1" ceramic chip that would go into a sheen diagnostic machine. This ceramic chip was opaque, and the constancy had to be so accurate that even a .00001% deviation from their specs. was inadequate and brought us back to the drawing board and our labs were so intensely frustrated that it took months to finally come to a successful conclusion that was accepted and finally the contract. The manufacturing end took enough time for quality and consistency and can we produce the 1/4 of a million with the same outcome as the original sample provided by the industry. Man, that was a real task to say the least. Many sleepless nights. Same went for reproductions in the antiquities from museums. This was our specialty, but just to mention what the company like BLEG has to go through to get the contract. The clients under these negotiations have the last say and the company if given the contract will be well deserved.
There are 3 important factors that you must understand when you take a position in a penny stock. The first is the share structure. What kills every penny company is the dilution of the share structure and it is indisputable to argue the fact that this one issue isn't the greatest negative to your ROI. The second is the business model. Does it have standing, and can it uphold the dominate interest with respect to rev and in a growth progression that is needed to continue through the business cycle for expansion and financing without the dilutive factor. The third is the management team. Does the company have the expertise in it respective field and does, this is important have the interest of shareholders concerns and updating said shareholders on every turn on the progression and missteps.
Al 3 of these attributes are in the company's favor. The company reduced the O/S shares by 2b and that is a big deal and shows that the company has the intent to build the business model from within and not on the backs of shareholders through dilutive nature. The business model is a concept that is revolutionary with respect to cannabis, which is and will gain much more popularity as more and more states recognize the viability for taxing and other reasons, but more importantly, the company is venturing in byproduct items that have appeal in broad sectors and with approval after clinical trials can only benefit the company as a whole with the utmost legitimacy. of FDA and other interested parties. Also, and this is important, the Vertical Integrated Structure. The company has in place every facet of the sequenced of the business model from the raw material through the manufacturing process onto the sales end into the public domain. This part allows the company absolute control from beginning to end without outsourcing that otherwise would create unnecessary bottlenecks and production delays. The last but not the least is the management team. So far, the company has shown transparency and the desire to keep shareholders in the loop. Also, the team has and is the original team before the company acquired their respective industries and this is very huge endeavor that allows the team a coordination that otherwise would be a stage of Imbo due to a training period that now doesn't exist, and you have harmony over the whole process.
Now we move forward into a growth period with an exciting company and a business model that is fairly new with respect to a business venture that is on the ground floor and the only way is up. I stand by my target of .01-.05 through mid-way 2025. The opportunities here is so great that after last week's downdraft, this issue is an absolute buying opportunity and feel you should take advantage and hold long. The next assessment will be June 2025. To give the company 1 year is certainly a reasonable objective for it to take their plan to the next level and that is a Nasdaq elevation, but that is down the road. Now it is in your court to fully embrace what a growth company feels like, and it is a buy and hold.
Remember, we have the May 15th quarter this week.
See you all on the trading floor tomorrow and Happy Mother's Day.
Have a good day
varok
I can understand your anger, but it is misplaced. For you to call me a pumper is a little much. I have only 12 posts on this thread, hardly a pump issue. Just because I don't post doesn't mean a damn thing. I have been here since 2000 and the 70th founder member on ihub and have only 2100 posts. My posts are analytical in nature. You can disagree whatever, your choice.
But I will say this. I have been trading penny stocks over 40 years and I know this venue very well. I can look at a penny stock and understand within 10 mins whether we have a winner/loser or a trader's dream. I know all the pitfalls and the trading algorithm, and I definitely understand the business model if it is good excellent or just plain junk. I know about share structure and the negative in convertible debentures and other means that keep a penny stock active and alive. And above all I understand reading the tape.
So far, my assessment of BLEG is a solid company with a very attractive business model and it is one of a very few companies in the penny arcade that has even a remote chance of survival from pennies to, yes, I will say a dollar. When? Is anyone's guess and it is a guess. The only hurdle that plaques a penny stock is not having the viability to stay in business through the means of a very solid management team and the understanding of financing without the dilutive nature. Thus far, all indication appears the team of BLEG is very cognizant of the shareholders interest in mind. As long as the company can maintain a very low dilutive nature at an absolutely minimum, we are in good shape at the present time. If this changes, we will need to make that assessment at that time. But for now, we are in great shape, and I expect that to continue for at least through 2024 and the 1st half of 2025. At that time, you will understand what I'm talking about. For now, you should've just hung in there and not run your mouth on something you don't know what you're talking about and should not have let your emotion get the best of you and you made a mistake in selling at a lost. That move was very premature.
I never like hearing folks lose monies, but really, you should've just hung in there and if the reason is because you could not afford to lose than you should not be in this venue.
Have a good day
varok
Good morning,
I certainly do not want to belittle the folks that sold into this major pullback, but I understand the anxiety that took place. Profit is profit and the folks that sold into this, this session allowed this to happen. First let me say, MM do not look for shares, they leave that up to us. Their position is always to accommodate given desire and this morning they obliged by taking it down as the algorithm pressure was quite evident. Make no mistake! This issue is going back up and thus far, the volume is very low indicative of emotional traders that are selling into this without much understanding. The only reason is the Monday high of .006 and trailing down brought on anxiety that resulted in whether it be pennies for profit or whatever, they exited and more power to them. No fault with that and one should always remove profit when they can.
Heck, I sold some into the high on Monday of .006 and now back in at .004. I believe this will be a .01 in short order. As long as the company does not dilute, we are in a position of great highs beyond .01 and that is a fact! The business model and the corporate structure is very unique in the penny arcade and the company has all the attributes in its favor.
Awesome buying opportunity and folks I know what I'm talking about. This is a great play people. Yeah, we may be going into the summer doldrums, but this issue has too much going for it and we have the financials on May 15th and I'm sure other information will be forth coming.
Have a good day
varok
Silver-Hammer-pulls-the-plug-on-shafter-project-purchase-2024-05-07
https://www.miningweekly.com/article/silver-hammer-pulls-the-plug-on-shafter-project-purchase-2024-05-07
Good morning,
First, I would thank many here for the kind comments on my Sunday Newsletter.
We started out this morning on a strong hold with minimal sellers this is a very good sign that shares are held in the faithful hands. Many here are now in and the fence-sitters are waiting for further direction from the company. We will get an announcement from the company with respect to the inspection on the manufacturing facility and why I believe for the current climate. We are trading exactly like an investment graded issue.
Expect the 1st quarter financial to be out by May 15th and if the past is any indication, it will be on time. We are now in the growth phase so for any financial statement will resonate with much anticipation on the rev.
Now I would like to address something that the company will likely do within the next couple of weeks, and this is in reference to obtain an infusion of much needed capital. As we are witnessing, the company is in the growth stage and to compliment this aspect of the revolving situation, the company is in the need for expansion which will require additional investment capital going forward. There are many avenues the company can take on how to obtain capital and I believe the way is through a nonequity-based instrument program and involve through either a bridge loan or a VC entity. I believe the company will be shareholder friendly and I base this on the recent attempts the company made to lessen the burden of lowering the share structure and the current setting of No debt instrument to the non-detriment of the dilutive factor. The move the CEO has made is very promising and shows his intent to put the forward equity financing package as a last resort. The company is showing positive figures to be able to be able to obtain financing through conventional means and this should bode well for us shareholders.
I base this on the lack of cash on hand and the rev. is enough for operating expenses in running payroll and the monthly expenditures in maintaining the natural form of running the company, but not enough to elevate the company to compliment the expansion that is going to be required to move forward and beyond and during rapid growth phase the company is on. This is going to happen and as I have mentioned it will benefit us and our ROI going forward.
It is going to be an exciting week to May 15th.
Have a good day
varok
The Sunday Newsletter - BLEG
Let's recap last week:
The shares are tightly held in strong hands and the trading range and who is in control is absolutely shown that we traders are in control. You can see the resiliency of a strong share structure and what effect it has on the price movement. The weekly chart is absolutely a beautiful sight to see. in the mid .0005We had two days of a downdraft but was short lived and only presented shareholders with opportunities to average in and get lower costs simply to anxiety from shareholders that have lost control of their emotions and trailed the negative sentiment in selling. Only to be amazed how we bounced back that was Wednesday on the misunderstanding on the OTC misclassification which was remedied the next day. I noticed looking at the chart for Friday and noticed another downdraft and this one appears to be somewhat more significant and wanted to confront this with real interest and found by cruising through ihub's posts that somebody wrote that Redditt opened a trading thread. Now this made me feel somewhat relieved since the young Turks over at Redditt do not play well with other children and happen to play outside of their sandbox and throwing sand in everyone's gears. That group over there are notorious for disrupting normal events and believe they caused the dip. As you can see, after the downdraft we went back to normal order and just showed how resilient the trading sessions for the week has been from the previous day's but still within the support of .0055 where we ended Friday with a perfect setup for this week.
The more I look and analysis the company the more I really like it. The main positive is the company currently does not have outstanding promissory, convertible notes, convertible debentures. This is the attractiveness of the company. Reason why I say this is that it is extremely difficult for a Penny Stock to conduct extensive program of Bio-tech research not to have these debt instruments. They have evolved into a very viable company and has put us on a path for solid growth going forward. The R/D is behind us and now we move into a new phase and execute their hard work into an FDA approved business model. The clinical trials.
This phase is the most important and allows the company to maximize their R/D efforts into a legitimate and save environmentally process and very much needed to move forward. It is this stage that will determine the viability of the company's business model. The are a few stages of Clinical trials. This week we have been getting information via twitter that the manufacturing plant is getting their inspection and of course to move forward this has to get the seal of approval before the next step. Let's hope this approval come through without hiccups.
The clinical trials on all companies can take 2-7 years and the latter is usually based on pharmaceutical companies with extensive medical saving medicines like cancer and such. We are not in this category, but nevertheless we do have a product that is eventually going to be used by humans and the procedure in clinical trials is as detailed and exact, but I believe, that a fast-track method and the process won't take as long giving the nature of the product itself.
The corporate structure is in itself a really smart endeavor on the company's part.
Branded Legacy, Inc. is a holding company that specializes in alkaloid extraction, refinement, and synthesis, as well as formulation and co-packing. Its primary focus is the commercial development of alkaloid-infused products such as vapes, tinctures, topicals, and gummies. We have a secondary focus on brand development, marketing, and overall sustainability. This on the surface details what the company is all about, but the underpinning or its corporate makeup is what is very important and just plain smart in the building the entire thesis.
See the company is built on the Vertical Organizational Structure: This departmental structure is an absolute way of allowing all steps of the company to be run by inhouse top tier management and its departments to the raw materials to the end product and finally into the sales end and onto the public domain. No disruptions from outsourcing or any delays that encompass many companies that rely beyond their control. Not here. The company is fully integrated. Good for the company and great for us shareholders ROI.
The acquisition of the various partnership/collaborations is what makes this a superb company. They kept on board the same teams of top management that was in the acquisition allowing for a unified transfer without embarking on a new team to familiarize with the organizational aspect that narrowed the time constraints for up and running into the new entity. Smart indeed.
List any subsidiaries, parent company, or affiliated companies:
Total Refinement Solutions, LLC (DBA Royal Biotek) is a wholly owned subsidiary with a proven track record of quality and efficiency. Our operations focus on the extraction, refinement, synthesis, and formulation necessary to support our co-packing endeavors. We have patentable intellectual property including product formulations and standard operating procedures. We perform extraction/refinement services both for our in house brands as well as on contract for our external partners. Our assets include a state of the art lab facility capable of processing several hundred kilograms of raw material per day.
The Alcannabist, LLC is a wholly owned subsidiary specializing in proprietary formulations encompassing a range of wellness products containing CBD, Mitragynine, Kavatones, and functional mushrooms. Its mission is to provide effective, natural solutions for various health concerns while also serving as an open market hub for marketing and distributing related products. With several product lines specifically formulated to treat migraine headaches, anxiety, pain, sleeplessness, and others, we offer vapes, gummies, tinctures, and topicals.
Rocket Web Development and Design, LLC (RWDD) is another wholly owned subsidiary, and is a leading web development company that has been developing and supporting various businesses in multiple industries for the past 7 years. Our consistent growth over this period has been a testament to our commitment to quality, innovation, and client satisfaction.
RWDD is revolutionizing our digital capabilities with its bespoke web development and comprehensive digital marketing solutions. This strategic integration not only enhances our subsidiaries' online presence but also extends these advanced services to our clients, promising a significant boost in digital engagement and market reach.
MaryJ Pharmaceuticals, Inc. is a wholly owned subsidiary whose primary service is a full-service mobile provider in the Medicinal Marijuana & HEMP industry. This would include everything from portable extraction, packaging, HIPPA compliant RFID tracking from seed to sale, delivery services, white labeling, retail products and research & development
You can see the importance of the Vertical Organizational Structure. Totally in the right direction a perfect setup for the growth of the company.
What can we now expect with respect to Shareholders ROI in the coming weeks and months?
We will be getting news on updates with the manufacturing process and let's hope we get a good bill of health. A passing grade to move us forward. I see that if all is well, we will move into copper no later than the end of May. In other words, I expect us to see copper in the next 2 weeks without much difficulty. This is also with the upcoming quarterly expect on May 15 for the first quarter of 2024. This will give us direct and hopefully good numbers. The numbers on the recent acquisition of MaryJ won't be in this quarter, but certainly in the 3rd after the growing season. The company was halting operation because of Covid.
Folks this is in a nutshell the overlook of what is coming and expected in the next few months going into the end of the year. As I have mentioned, the share price of .01 will happen shortly and once we move into clinical trials and the positive outcome to allow us moving forward .02.05 beyond the first half of 2025 is very doable. Our trading ranges from now to end of year will be .01-.025. It is after the clinical trials where the rubber meets the road.
See you all on the trading floor tomorrow.
Have a good day.
varok
Good afternoon,
The trading session today has proven how resilient this company is with respect to the share structure. The shares are tightly held in strong hands and the trading range and who is in control is absolutely shown that we traders are in control. Notice the spread in most of today's action. Whenever you have a spread like this it bodes very well for us and lowers the manipulation aspect from Market Makers. These boys are sitting on the sidelines and the algorithm is on its best behavior.
What is needed now is a decent catalyst for us to move into copper land. It will happen, that I'm sure of, but it will take an effort by the company to give us this nudge, but there is no doubt that is where we are heading.
So far today we are back to where we should be, and the chart is a beautiful sight for sure. Certainly, a perfect setup for higher highs.
Expect news in the coming day/tomorrow or certainly next week and off we go. Would be nice to get a Press Release tomorrow so we can chat about it over the weekend.
A close on .006 would send a very positive message.
See you all on the trading floor on Monday. Long weekend for me.
Have a good day.
varok
Good morning,
Folks we are now in regular order with OTC and the CEO has proven his metal and now we can move on with discussion on the growth aspect of our company.
It is important we articulate what this company does on its business model with respect to the all-important growth aspect that will reflect the share price. This needs to be in the forefront for new members coming in to understand what the future holds.
Once we move into the clinical trials it will start to get really exciting and the company has brought into the fold a superb individual who has a strong resume in this area.
Dr. Mark T. Hamann serves as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery, Biomedical Sciences, and Public Health at the MUSC Colleges of Pharmacy and Medicine1.
He also holds adjunct appointments with The University of Maryland’s Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine1.
Recent Appointment:
Branded Legacy, Inc., a trailblazing BioTech holdings company, recently announced the strategic acquisition of Sycamore BioPharma, Inc.
As part of this acquisition, Dr. Mark T. Hamann has been appointed as the Director of Clinical Trials at Branded Legacy23.
His expertise will enhance efforts in developing novel pharmaceuticals and streamline the FDA approval process, particularly in clinical trials2.
Collaboration and Synergies:
The collaboration between Branded Legacy and Sycamore BioPharma aims to unlock synergies across various business facets.
Leveraging Branded Legacy’s web properties, brand management, and marketing expertise, they intend to maximize the reach and impact of Sycamore BioPharma’s groundbreaking wellness solutions2.
Overall, Dr. Mark Hamann’s addition to Branded Legacy’s roster is a significant step toward advancing pharmaceutical research and development, benefiting both the company and the broader healthcare industry.
Today we will move higher and probably touch .007. The volume will be awesome with many new shareholders getting in on the action. I expect some sort of announcement coming that will further the manufacturing aspect of our company.
When we move out of the gate, the move into .006 will be aggressive so for sake of stabilization wait 15m for it to settle in. Don't worry about missing out, there will be plenty of moments to acquire and most on this thread should've averaged in yesterday with the downdraft that provided just unforeseen buying opportunity. If I may say on an unfortunate misunderstanding. However, we are now good to go and enjoy the current climate, because folk's, it is going to just plain and simple, get really exciting for the next few months.
Have a good day.
varok
Expect an announcement very soon. Something is in the works.
Have a good day
varok
Good afternoon,
Well, looks like we may close on a perfect note. Just love the churn this morning and elevated us to a much stronger position.
We took out many weak hands and what is left is an absolute strong chart for the next resistance level.
We now have our support folks and anybody that sells now is for their supper, because they certainly now have gotten wind that this issue is strong and a CEO that protects our back. Nice to see he how came out and took responsibility for the misunderstanding. He didn't need to do that but shows a level of having a direct interest in sharing with shareholders that he is with us. Kudos for him.
Oh, how I love the penny arcade.
See you all on the trading floor tomorrow.
Have a good day
varok
Folks make mistakes based on emotion and anxiety without self-discipline.
One should never sell or buy within 15m of the open. It is within this time frame that you're at the height of anxiety and one's mind trades on not wanting to miss out when the criteria is a buy and when the criteria is a sell, they evolve into a panic mode.
First, one must adhere to the 3-day rule. When a runup, especially when it runs straight up, never buy beyond the 3-day run, because in 90% of the runs like this, there is a major profit-taking and this creates a downdraft. This presents in most cases a buying opportunity to average in. However, there is a part of your brain that panics and you bail. In many cases, one falls victim to the 'falling knife' scenario. wanting not to miss out or panic into sell for the sake of POC- Preservation of Capital.
Welcome to the penny arcade where big money can be made and with equal loses as well. It takes discipline. We are good here and this issue is going a lot higher, and we will close maybe slightly lower just to realign the charts, but I can assure you this pullback today will be short lived and, in my opinion, is simple an opportunity to acquire additional shares for the next leg up.
The yield sign on the OTC should not matter since the OTC always seems to lack timely updates, but whatever, this too will get corrected, and today's session is nothing more than an opportunity. We know what we have. Control your discipline.
Have a good day
varok
No worries here I have large buy orders in to take advantage on the churn. I expected this since the last few days were straight up without a pullback and we have that now. We are cleansing out the bottom feeders.
Have a good day
varok
YIELD Sign in OTC Markets:
In the OTC markets, you might come across a “YIELD” sign associated with certain companies.
This sign indicates that the company has not provided current disclosure to the public markets. It may be unwilling or unable to provide information to regulators, exchanges, or OTC Markets Group
Good afternoon,
Today's session has been very positive and denotes the right tone for a company on the path for growth. Since 4/4 the price spiked into an uptrend to.0035. on 04/9. The volume during this brief period was high and was contributed to the PR 4/4 and 4/9 on great news. Then we churned and exactly what we needed for the next leg forward. From this point to today the forward momentum has been very positive and created the right trading pattern with small pullbacks.
Today's session showed strength with small pullbacks. This churning is very healthy for a continued uptrend. Nothing ever goes straight up and what has transpired with respect to churning is exactly what the momentum needed for the next move into resistance or new highs. We are building a nice support in the area of .005 and this is definitely what must happen, and it did. We are going higher folks and currently the upside momentum is in our favor.
Allow me to mention why I posted a target of .01. I tend to be very conservative on price targets. However, given the low daily average volume This target is very much in the short-term and I will now for sake of conversation that by end of 2024, the target is being raised to .02-03+. My reason is that the company has elevated its program beyond R/D. The company is now in a growth pattern and when new shareholders fully realize from additional positive PRs on collaboration and partnerships, I believe the street will be generous in giving the company a 20$m MC by end of year and if the company can maintain a very modest approach on the dilutive factor, we are good to go on this very achievable goal of .02-03.
Have a good day
varok
Good morning,
I have always been apprehensive investing in penny arcade Bio-Companys for the obvious reason. They are dilutive nightmares without much success.
I have made an exception with BLEG. I was led to this company by a very good friend and really wasn't impressed, but after considerable DD, I have decided to take a modest position.
First, I have to say that the share structure is very attractive for a Bio company at A/S 900m O/S 676m. The very promising share reduction shows the company's intent is to maximize ROI for share shareholders and this is a big deal. Also, the CEO holds majority and the protection against greenmailing is well in place. This protection is a mechanism against hostile takeovers maneuvering through backdoor schemes. Very promising.
The attorney letter from last year bla,bla,bla is all good and basically denotes all is well.
Net income for 2023 at 3.8$m is very nice indeed and current assets is well in line with a solid MC of 2.2$m, which incidentally allows for a solid growth moving forward with a very limit on any dilutive impact. I like it!
Assets verses Liabilities is well in line and very reasonable to say the least. Very positive indeed.
The strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union. This by far is most promising!
White paper concept is usually written by a company to illustrate their knowledge and expertise through facts and evidence, but it should not advertise or endorse a company’s product. White papers are designed to present persuasive research, detail a problem at hand, and provide a solution and is essential for the further guiding to move through the FDA. Company is on the right track and should elevate the ROI for shareholding understanding.
The company is on the path to build a solid foundation to retail their product through white label contracts and this only will propel the company a rev stream in a fast-track setting and the exposure is fairly optimistic and should bode well in the near-term going out in the long run for us shareholders.
The company isn't shy about keeping shareholders informed and I expect major announcement on retail venues in the coming months through the end of year 2024.
I see a price target .01 within the 2024 year and will give us a MC of 10$m which in my opinion is very doable and reasonable.
Solid buying opportunity at .004-.007
Have a good day
varok
Well, let's put it this way. Usually, a 5th decimal trade is considered a non-retail that can be sold as a retail trade. However, a 6th decimal is definitely an entity non-retail and can be a wholesale between the company's host MM and another broker and this may be a cancelled trade for retirement. We will know on the update. I believe it is a retirement back to the treasury.
One thing that people need to understand is that in this case the volume (150m+) number far exceeds the current volume at the execution was 3 times the daily volume. Remember, MM cannot hold inventory, that is against the SEC rules and they/MM know the penalties are very severe. When this 6thand5th decimal trade went off, the volume for the day was 44M at 15 min before close. So, it has to be a retirement trade.
Have a good day.
varok
Note the trades that just went off in the 6th decimal 99m and 14m at .000001. I think the company just retired another 100m+.
Have a good day
varok
It is how I explained in my previous post. The leverage pivot maneuver. Find a company with a return in a matter of days, week. Go to the most read breakout thread on ihub. It is a very risky venture, but it does work if you can find another accomplice/stock. Just for the record, I don't short pennystocks.
there you go.
I'm not saying it can't be done. I know there are brokers that allow with very high interest rate.
Geez Hippy didn't I just say that. You gotta stay of the weed man.
About Shorting a stock.
We all know the reason by shorting a stock. Let's refer to PSRU.
Shorting a penny stock isn't illegal, but many brokerage houses don't allow shorting under $5.00
Most brokerage houses don't allow too short a pennystock that trade in .000x. Obviously, understanding to short a .0001 issue makes no sense since the issue isn't going lower. So, if you can find a broker to allow one to short a .0001 stock you use a leverage pivot maneuver. You find a broker that allows you to short a .000x stock and say you acquire/short to sell 100m at .0001 for 10$K. Now you turn the funds into another pennystock at let's say .0002 with your 10$K and sell at .0004 and make a quick 20$K and then turn around and cover your short position at .0001 and you have just walked away with 10$K profit. This is the only way where it makes sense. Catch is can you find a broker that will allow such a scheme.
With PSRU one can be assured that the stock isn't going north so you do not lose out and can comfortably cover without lose, but interest will apply, and one can find dozens of pivot maneuvers just by visiting ihub.
Have a good day
varok
Good morning,
I received a message from a poster about how a company buys back stock if the company has no cash.
First let me say this. I realize many on this thread don't like my analysis on this company, but my post whether it is with this issue, or any other issue is a counterbalance to the basic sentiment from what I'm reading here that is not always popular.
Well, there are a couple of ways, but in the end, it still means the company has to raise the cash through regular business conduct for revenue. However, there is another way and that is bring in a VC who puts up the monies for a buyback. Understand, this part is not attractive to a VC since these individuals or entities generally don't approach a company or back a company unless they see a return that is absolute. Most VC will not take a position unless the company reduces the share structure. So, I don't see this as an option since it is still a Note, like paying your bills from a credit card.
The company may try a common practice of taking on a Convertible Debenture to execute a large share buyback, but this is just prolonging and starting the dilutive process over again, but may have a restriction, but still a note. This would give us the catalyst in the near term, but at least we can exit out.
So, now it comes to, can the company bring in enough REV to compliment a stock buyback. For you shareholders, this is your most crucial question. Can the company be a revenue generating business concern? This is our only option.
Either way you look at it, the company needs to absolutely take down the blotted O/S. This is your major objective to even assume that the company will be viable going into next year.
Currently none of us that hold can do anything but hold. We are unfortunately stuck. For myself, I knew this coming in and betting that at least the share price will get one bounce, albeit a target of .0003-.0005 is where the exit begins.
I too have concern and do not consider the issue as a viable company that can ROI.
Have a good day.
varok
The Sunday Newsletter,
There is much emotion and anxiety playing out during the past week's session.
First let's start with the company's announcement going back a couple of weeks on share reduction or buyback. The company announced on X a few weeks back that they would reduce the O/S. For the reduction to reflect the actual via the transfer agent takes a couple of days or a couple of weeks. We got an update last week-Friday with a 100M reduction. This is probably a true figure since it isn't difficult to predict on any given day on how much the buyback amounts to. As I have mention from my last post (see my reply above) on the particulars on the SEC rules.
There is so much hyperbolic predictions on this thread pertaining to the direction on where the company is going. It doesn't benefit anybody on this thread looking to further their due diligence and answers only to read these wild predictions that are so far out there that any reasonable qualified analyst could never even stand behind such claims. I realize that many would like to see this company's potential come to fruition, but currently this is a long shot and a very or extremely risky trade for ROI. Welcome to the penny arcade.
As I mentioned before, the company has to stay within 25% of the volume for buyback and selling shares within the sessions volume. We don't need to keep looking for the numbers from the transfer agent's confirmation for the actual amount. You can see just from the volume going back when the company announced on X how much is being taken back or retired. It shows that the company reduced it about 100M and is on par. Face it folks, the company on most days going back weeks really doesn't have the volume to amount to any major reduction. A real significant amount has to be around 25% of the current O/S. This amounts to 2.5b reduction and anything less is basically a nonstarter.
For the folks that continue to buy. Stop it now and just hold what you have and watch where this goes. I can tell you with almost certainty that if you continue to overburden your continued buying you will have a very rude wakening when things start settling down and that will eventually come into Fall going to end of year. Some have shared with the board on how much they own, and I again can tell you that it doesn't matter. What I will say, if you own over 100M you are playing in a very risky venture and the risk/reward is against you.
Under the current O/S this company will never hit .01. The law of averages is against this issue under the current setting and if the share reduction isn't reduced to a considerable level, most of you will have proven that 70% who participate in the penny arcade will lose their principal amount and eventually will sell just for 'Preservation of Capital' or POC. This is a fact!
I generally never take the advice in the penny arcade on what is said on X. You have to take these statements from any company on X with skepticism and this company referring to reduction as "significant" is thus far, nothing more than BS. However, this may change, but the change must accompany a catalyst from the company since any future driving force to elevate the share price will be null and void and we will all be holding worthless shares and whatever amount you may have spent is a lose.
This is one subject that many can't seem to get a grip on and that is the dreaded R/S. When any company states that they are not going to do a R/S is only stating a vague response and generally is just too quiet down the obvious sentiment. Nobody wants to hear that horrible move, but with this company, it has to be part of the conversation regardless of the statements on X by the company.
I'm going to make a prediction right here and now. This company has to reduce the share structure by at least 25% or greater by the end of the year and they must present shareholders with a very sound catalyst to implement this part of the program. I do however feel that .0003-.0005 is achievable in the short-term, but it needs a catalyst. Without a catalyst we will linger down here in the doldrums for how long, is anybody's guess. The eventual outcome is not going to be very satisfactory to shareholders. If by the end of the year and NO significant share reduction as mentioned the company will never be able to survive NOT doing a R/S and now, I am more inclined to think that a R/S will happen by the end of the year. The company as with most companies will give a high noted reason on why they will need to do a R/S and shareholders never have a chance to counter this discission. If one does happen and no significant change in the share structure expect a R/S around 1: 2,500.
For all who hold and maintain that hold since it doesn't matter at this point, start exiting out once this issue starts moving north and consider the number of shares in retail hands remove your principal with extreme prejudices early.
Take it for what it's worth, I am a very good analyst on the inner workings of companies in the penny arcade and generally when I say there is a high probability on a R/S take it to the bank.
See you in the fall.
Class dismissed.
Have a good day.
varok
Good afternoon,
I see there is much talk about the share buyback and feel that the 100m reported on the OTC update seems just plain insignificant. It is to say the least. However, volume on this issue is sporadic meaning there are days when volume is extremely low and as noted this past week on Monday, Tuesday and Wed. we had decent volume, and it was on these days that the company executed their buyback.
So, let's not bash the company yet and give it a chance. I have mention in one of my previous posts that a significant buyback has to be around 25% of the O/S to even qualify as a substantial amount and this means for price movement. Now there are rules because it is only 100m. The SEC requires a strict buyback to adhere to 25% of the company's daily average volume and this after a lackluster volume going back weeks, this past week allowed the company to buy back their shares. We had huge volume. Also, the buyback has time constraints and price as to when what and how. Since the company has a no bid and trading at .0001 for months obviously the price doesn't really have bearing, but time is based on the hour after the open and can run through the trading session and 1/2 hour before the close. They meet these parameters only the volume is the burden since the company needs volume and why the hit the Twittersphere's with a reduction. This was simple an approach to increase the volume thus buyback.
The buyback can only come from a certain MM or single dealer on any given day. These purchases can't come from a roundabout network. It is generally the host MM that officiates the buyback on behalf of the company.
As you can see that since volume is on most days of insignificant quantity, you obviously can't execute a buyback. This is my major concern since the company is not big on releasing major news announcement or National Press Releases, but through venues that are very isolated or not well disseminated through the investment community. The company can now disclose daily repurchase activity as they have through tweeter, but as you have noticed they are vague, but nevertheless, it has to accompany the quarterly or 10K as attachment. I'm sure these updates will happen, but we are seeing the updates via the OTC website in the interim almost on a daily when applicable.
So, we can only surmise that if volume increases to a point of reasonable significance, we will see a certain amount of buyback, but until the lackluster and no real catalyst from the company expect the same outcome with real teeth into the reduction and that is the current problem we face and a real detriment on our ROI. Still optimistically bullish, but with concern.
See you all on the trading floor on Monday.
Have a good day
varok
I think I will take a stab at your very good question.
See, the MMs know that this company has rolled out on average about 1B shares and as such the algorithm is set in place to give credence that these shares have been moved in retail hands.
Market Makers know how many and where they moved and generally when we have maintained a no bid and the lowest common denominator being .0001 allows the market maker to jockey back and forth really without much resistance. When a company has traded within a no bid for months the market maker arbitrarily maintains a very large number of known shares in retail hands on the lowest common denominator being .0001 without much resistance and absolutely O support since.
Notice this morning at the open when a slew of shares was being tabulated in volume of under 20K the algorithm was spooked and scrambling to fill and example of the jockeying from various sources.
Just wait when we get back to normal trading patterns, i.e. like a bid and a ask on solid footing without the back and forth on nothing more the realignment that is based on the AI of the algorithm.
Currently market makers are really not in control and that will certainly change when the momentum picks up. It is the presetting of the algorithm that was put in place long ago because of the continuous no bid and endless shares hitting the market.
Have a good day.
varok
Good afternoon,
A poster, Janet Canada mentions the black ? on volume.
I'm speculating on the limb on this.
Further thinking about this is that all trades from #22 to current went back to the treasury/retire via the company making it as 'masking' Certainly folks did buy, but no sells and the entity for the company took them back into the treasury/retire were all the shares from #22 to current.
Of course, folks were buying, but I don't anybody was selling. Now, I don't know for sure if anybody put in a sell at the ask and if it took. Since the company mentioned a buyback this may be the indicator that all shares from today's action started at #22 going to current went back into the treasury/retire.
Well, have at it folks, this is my take on this strange setting.
Regardless I'm bullish on this company going forward and my near-term target is .0005 and the churning will be huge and awesome.
Have a good day
varok
Strong Buy at .0001!!!
Your last chance to get in on the bottom.
Near term target .0005.
Share reduction numbers update announcement coming shortly, then BOOM!!
Have a good day.
varok
25% of O/S or roughly 3B. We will start there since that is only $300K